(Q40857526)

24 September 2017

title

Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma (English)

1 reference

24 September 2017

Harrison LH Jr

1 reference

24 September 2017

Schwarzenberger PO

1 reference

24 September 2017

Byrne PS

1 reference

24 September 2017

Marrogi AJ

1 reference

24 September 2017

Kolls JK

1 reference

24 September 2017

McCarthy KE

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

The Annals of Thoracic Surgery

24 September 2017

published in

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

407-411

1 reference

The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901557-5

Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901557-5

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901557-5

Intrapleural photodynamic therapy: results of a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901557-5

Multimodality Management of Malignant Pleural Mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901557-5

Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901557-5

10.1016/S0003-4975(00)01557-5

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference